相关实验视频

Updated: Jun 5, 2025

Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages

Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages

Published on: August 12, 2019

巨细胞P2Y12调节铁运输,其抑制可以防止动脉样硬化

Yang-Xi Hu¹, Hong-Min You², Mei-Rong Bai³

¹Department of Cardiology, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China; Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China.

Journal of advanced research

|December 14, 2024

概括

抑制P2Y12通过抑制NF-κB信号来减少巨细胞中的铁保留,从而防止动脉样硬化进展. 这一发现突出了P2Y12的发现.

科学领域:

心血管生物学心血管生物学
铁的新陈代谢铁的新陈代谢
动脉样硬化研究动脉样硬化研究

背景情况:

铁在动脉样硬化斑块中的积累是有害的.
血小板P2Y12是抗血小板治疗的关键标.
之前的研究表明P2Y12参与铁代谢.

研究的目的:

研究P2Y12在巨细胞铁代谢中的作用.
确定P2Y12对系统铁平衡和动脉样硬化的影响.

主要方法:

对人体血清铁和P2Y12抑制剂的病例控制研究.
缺少P2Y12的斑马鱼模型用于铁过载和动脉样硬化.
在实验室中使用与P2Y12敲击或激活的小鼠巨细胞进行研究.
RNA测序和药理学的方法来阐明机制.

主要成果:

使用P2Y12抑制剂与血清铁的增加相关.
斑马鱼的P2Y12缺乏减少了动脉样硬化和铁的保留.
在巨细胞中抑制P2Y12降低了费里丁,ROS和炎症性细胞因子.
抑制P2Y12抑制了NF-κB p65酸化和肝素的表达.

结论:

在巨细胞中抑制P2Y12可减少细胞内铁的保留.
通过抑制P2Y12抑制NF-κB信号的抑制是关键机制.
向P2Y12可能为动脉样硬化治疗提供一种新的策略.

关键词:

抗血小板治疗是一种抗血小板疗法.动脉样硬化是一种动脉样硬化.铁化是铁化的一种.铁过载是因为铁过载.巨细胞是一个巨细胞.P2Y1212 这是一个很好的例子.

更多相关视频

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Published on: April 3, 2017

Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo

Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo

Published on: February 5, 2019

相关概念视频

Inflammation

Inflammation